Tumor pathologic variables | Receptors (core biopsy) | Pretreatment hemoglobin parameters | Sensitivity (%)/specificity (%) | PPV (%)/NPV (%) | AUC (%) (95% CI) |
---|---|---|---|---|---|
IDC/ILC, NS, MC | Â | Â | 76.2/74.3 | 65.7/83.1 | 76.9 (59.60; 95.46) |
IDC/ILC, NS, MC | TN, HER2, ER | Â | 71.1/80.7 | 70.5/81.6 | 87.1 (71.54; 98.63) |
 |  | tHb | 58.1/84.5 | 69.9 /75.9 | 76.7 (53.01; 96.64) |
 |  | oxyHb | 52.9/86.1 | 71.5/73.8 | 76.8 (54.60; 94.34) |
 |  | deoxyHb | 59.3/81.8 | 68.1/75.9 | 67.4 (40.97; 90.09) |
 |  | tHb, oxyHb | 60.3/87.9 | 77.1/77.5 | 78.6 (55.46; 97.08) |
 |  | tHb, deoxyHb | 64.1/85.2 | 74.3/78.5 | 74.6 (55.58; 97.31) |
IDC/ILC, NS, MC | TN, HER2, ER | tHb | 80.5/87.6 | 80.8/87.5 | 92.9 (82.76; 99.70) |
IDC/ILC, NS, MC | TN, HER2, ER | oxyHb | 79.9 /91.4 | 85.2/87.9 | 96.1 (88.91; 100.0) |
IDC/ILC, NS, MC | TN, HER2, ER | deoxyHb | 73.0/82.0 | 72.9/82.9 | 88.9 (74.94; 98.94) |
IDC/ILC, NS, MC | TN, HER2, ER | tHb, oxyHb | 92.5/95.2 | 92.5/95.2 | 98.2 (93.68; 100.0) |
IDC/ILC, NS, MC | TN, HER2, ER | tHb, deoxyHb | 83.9/87.2 | 80.7/89.7 | 95.1 (86.94; 99.75) |